Journal of International Oncology››2018,Vol. 45››Issue (8): 470-477.doi:10.3760/cma.j.issn.1673422X.2018.08.005
Previous ArticlesNext Articles
Jiang Li, Li Hui, Zhang Guiying, Mu Yibing, Liu Haitao
Online:
2018-08-08Published:
2018-11-01Contact:
Jiang Li E-mail:315346713@qq.comSupported by:
Research Project of Health and Family Planning Commission of Hunan Province of China (B2016221)
JIANG Li, LI Hui, ZHANG Gui-Ying, MU Yi-Bing, LIU Hai-Tao. Effect of miR145 targeting Six1 on invasion of gastric cancer and its molecular mechanism[J]. Journal of International Oncology, 2018, 45(8): 470-477.
[1] 韩雪, 李曼. 微小RNA与肿瘤上皮间质转化[J]. 国际肿瘤学杂志, 2014, 41 (12): 881884. DOI: 10.3760/cma.j.issn.1673422X.2014.12.001. [2] Nakagawa Y, Akao Y, Taniguchi K, et al. Relationship between expression of oncorelated miRNAs and the endoscopic appearance of colorectal tumors[J]. Int J Mol Sci, 2015, 16(1): 15261543. DOI: 10.3390/ijms16011526. [3] 赵娜, 张浩, 贺恒鹏. miRNA145在胃癌中的表达及临床意义[J]. 现代肿瘤医学, 2016, 24(11): 17601762. DOI: 10.3969/j.issn.16724992.2016.11.025. [4] Lee JW, Kim N, Park JH, et al. Differential microRNA expression between gastric cancer tissue and noncancerous gastric mucosa according to Helicobacter pylori status[J]. J Cancer Prev, 2017, 22(1): 3339. DOI: 10.15430/JCP.2017.22.1.33. [5] 王丹. miRNA145抑制肺癌A549细胞增殖活性的机制[J]. 江苏大学学报: 医学版, 2015, 25(4): 311316. DOI: 10.13312/ j.issn.16717783.y150041. [6] 何涛, 李国庆, 谢娟, 等. miR145对HepG2细胞中肿瘤干细胞增殖的影响[J]. 中国医药指南, 2013, 11 (31): 6263. DOI: 10.15912/j.cnki.gocm.2013.31.412. [7] 檀碧波, 李勇, 范立侨, 等. 胃癌组织中miR185检测的临床价值及与Vav3Rac1通路的关系[J]. 河北医药, 2017, 39(17): 25652568, 2572. DOI: 10.3969/j.issn.10027386.2017.17.001. [8] 王力利, 李勇, 檀碧波, 等. 胃癌及淋巴结组织中miR145的表达水平及其临床意义研究[J]. 中国全科医学, 2016, 19(29): 35583561. DOI: 10.3969/j.issn.10079572.2016.29.010. [9] Ono H, Imoto I, Kozaki K, et al. Six1 promotes epithelialmesenchymal transition in colorectal cancer through ZEB1 activation[J]. Oncogene, 2012, 31(47): 49234934. DOI: 10.1038/onc.2011.646. [10] 王密斯, 张荣花, 王琳, 等. miR185对肝癌细胞生长增殖及侵袭迁移的影响[J]. 第三军医大学学报, 2016, 38(17): 19181923. DOI: 10.16016/j.10005404.201601070. [11] 黄寰, 陆志锋, 陈晞明, 等. miR145通过下调LRRFIP1抑制血管平滑肌细胞增殖及迁移机制[J]. 河北医学, 2017, 23(5): 793796. DOI: 10.3969/j.issn.10066233.2017.05.026. [12] Terry L, Sheppard. RNA profiling: a better miR trap[J]. Nature Chemical Biology, 2015, 11(11): 828. DOI: 10.1038/nchembio.1942. [13] Olbromski M, Rzechonek A, Grzegrzolka J, et al. Influence of miR7a and miR243p on the Sox18 transcript in lung adenocarcinoma[J]. Oncol Rep, 2018, 39(1): 201208. DOI: 10.3892/or.2017.6077. [14] 樊瑞智, 李海青, 曹允友, 等. 微小RNA30a靶向调控Snail影响胃癌SGC7901细胞迁移和侵袭能力[J]. 中华实验外科杂志, 2017, 34(11): 19191921. DOI: 10.3760/cma.j.issn.10019030.2017.11.033. [15] 赵丽娇, 孙慧, 鲁静, 等. Six1基因异常表达促癌机制及药物靶点[J]. 现代肿瘤医学, 2017, 25(20): 33753378. DOI: 10.3969/j.issn.16724992.2017.20.046. [16] 曹燕飞, 任睿, 杨晔, 等. miR185靶向Six1对肺癌上皮间质转化过程的影响及其机制[J]. 临床与实验病理学杂志, 2017, 33(8): 879883. DOI: 10.13315/j.cnki.cjcep.2017.08.011. [17] Chang Y, Yan W, Sun C, et al. miR1455p inhibits epithelialmesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in nonsmall cell lung cancer cells[J]. Oncol Lett, 2017, 14(6): 69236928. DOI: 10.3892/ol.2017.7092. [18] Chang S, Gao L, Yang Y, et al. MiR145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells[J]. Oncotarget, 2015, 6(10): 76757685. DOI: 10.18632/oncotarget.3048. [19] Du P, Zhao J, Wang J, et al. Sine oculis homeobox homolog 1 regulates mitochondrial apoptosis pathway via Caspase7 in gastric cancer cells[J]. J Cancer, 2017, 8(4): 636645. DOI: 10.7150/jca.16018. |
[1] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[2] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[3] | Xie Shuping, Sun Yahong, Wang Chao.Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 157-165. |
[4] | Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180. |
[5] | Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190. |
[6] | Shao Huifang, Wang Xuehong, Lu Yongfu.Mechanism of action and clinical significance of CST1 in the progression of gastric cancer[J]. Journal of International Oncology, 2023, 50(8): 489-492. |
[7] | Zhu Siyu, Wang Xuehong, Li Wenqian, Liu Shu.Level of serum FABP1 and its relationship withHelicobacter pyloriinfection in patients with gastric cancer[J]. Journal of International Oncology, 2023, 50(6): 336-341. |
[8] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207. |
[9] | Ji Wei, Guan Quanlin, Chen Yarui, Jiao Fuzhi, Luo Qianwen.Correlation between blood lipid level and gastric cancer[J]. Journal of International Oncology, 2023, 50(3): 183-185. |
[10] | Fan Shanlin, Wang Pinxiu, Kong Fei, Zhou Yujie, Yuan Wenzhen.Progress in the study of predictors of tumor regression grade after neoadjuvant chemotherapy for gastric cancer[J]. Journal of International Oncology, 2023, 50(2): 112-116. |
[11] | Yang Jun, Li Rong, Zeng Jianchang.Clinical efficacy of Compound Kushen Injection combined with SOX regimen in the treatment of elderly patients with advanced gastric cancer[J]. Journal of International Oncology, 2023, 50(2): 82-86. |
[12] | Deng Lili, Duan Xingyu, Li Baozhong.Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma[J]. Journal of International Oncology, 2023, 50(12): 751-757. |
[13] | Li Jiayi, Wang Yue, Shang Lanlan, Xu Xing, Zhao Yan.Practice and prospect of artificial intelligence in diagnosis and treatment of gastric cancer[J]. Journal of International Oncology, 2023, 50(11): 677-682. |
[14] | Yu Xiaopeng, Feng Qingqing, Zhao Wenfei, Zhao Wenwen, Wei Hongmei.Application of targeted therapy combined with immune checkpoint inhibitors in the treatment of HER2 positive advanced gastric cancer[J]. Journal of International Oncology, 2023, 50(10): 631-635. |
[15] | Zhao Jianhao, Duan Yanchao.Research progress in the pathogenesis of extramedullary disease in multiple myeloma[J]. Journal of International Oncology, 2023, 50(1): 55-59. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||